Oxygen-containing MNBs may enhance the therapeutic efficiency of photodynamic therapy by degrading HIF-1α and increasing the generation of the ROS by simultaneously delivering oxygen and photosensitizers to the targeted tumor. The gene discussed is HIF1A; the disease is neoplasm.